- Home
- Publications
- Publication Search
- Publication Details
Title
TRPV4 antagonists: a patent review (2015–2020)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2021-03-16
DOI
10.1080/13543776.2021.1903432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation
- (2020) Ravi K. Adapala et al. BASIC RESEARCH IN CARDIOLOGY
- Recent advances in TRPV4 agonists and antagonists
- (2020) Brian G. Lawhorn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Elevated TRPV4 Levels Contribute to Endothelial Damage and Scarring in Experimental Spinal Cord Injury
- (2020) Hemant Kumar et al. JOURNAL OF NEUROSCIENCE
- Urgent reconsideration of lung edema as a preventable outcome in COVID-19: Inhibition of TRPV4 represents a promising and feasible approach
- (2020) Wolfgang Michael Kuebler et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Targeting pulmonary capillary permeability to reduce lung congestion in heart failure: a randomized, controlled pilot trial
- (2020) Glenn M. Stewart et al. EUROPEAN JOURNAL OF HEART FAILURE
- TRPV4: A Physio and Pathophysiologically Significant Ion Channel
- (2020) Tamara Rosenbaum et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transient receptor potential channels in pulmonary chemical injuries and as countermeasure targets
- (2020) Satyanarayana Achanta et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- Structural determinants of TRPV4 inhibition and identification of new antagonists with antiviral activity
- (2020) Pablo Doñate‐Macian et al. BRITISH JOURNAL OF PHARMACOLOGY
- TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions
- (2020) Wei Yang et al. Scientific Reports
- TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus
- (2020) Alexandra E. Hochstetler et al. JCI Insight
- The role of TRPV4 channels in ocular function and pathologies
- (2020) Brianna D. Guarino et al. EXPERIMENTAL EYE RESEARCH
- Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions
- (2020) Jaclyn R. Patterson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects
- (2019) Navin Goyal et al. American Journal of Cardiovascular Drugs
- Discovery of Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists as Regulators of Chondrogenic Differentiation: Identification of Quinazolin-4(3H)-ones and in vivo Studies on a Surgically Induced Rat Model of Osteoarthritis
- (2019) Masakazu Atobe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Evolutionary Insights Point to Allosteric Regulation of TRP Ion Channels
- (2019) Jacob K. Hilton et al. ACCOUNTS OF CHEMICAL RESEARCH
- TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice
- (2019) Maricruz Orduña Ríos et al. PLoS One
- Activation of PTEN by inhibition of TRPV4 suppresses colon cancer development
- (2019) Xiaoyu Liu et al. Cell Death & Disease
- Transient receptor potential ion-channel subfamily V member 4: a potential target for cancer treatment
- (2019) Suyun Yu et al. Cell Death & Disease
- Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)
- (2019) Carl A. Brooks et al. ACS Medicinal Chemistry Letters
- Activation of Transient Receptor Potential Vanilloid (TRPV) 4 as a Therapeutic Strategy in Osteoarthritis
- (2019) Masakazu Atobe CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4)
- (2019) Carl A. Brooks et al. JOURNAL OF MEDICINAL CHEMISTRY
- TRP Channels as Potential Drug Targets
- (2018) Magdalene M. Moran Annual Review of Pharmacology and Toxicology
- Transient receptor potential vanilloid 4–expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch
- (2018) Jialie Luo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms
- (2018) Zengqin Deng et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms
- (2018) Zengqin Deng et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model
- (2018) Joseph E. Pero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4)
- (2018) Edward J. Brnardic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells
- (2017) A A Peters et al. ONCOGENE
- Modulation of the TRPV4 ion channel as a therapeutic target for disease
- (2017) Megan S. Grace et al. PHARMACOLOGY & THERAPEUTICS
- 4-isopropylcyclohexanol has potential analgesic effects through the inhibition of anoctamin 1, TRPV1 and TRPA1 channel activities
- (2017) Yasunori Takayama et al. Scientific Reports
- Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference
- (2017) David Arredondo Zamarripa et al. Scientific Reports
- Discovery of novel 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 1
- (2016) Naoki Tsuno et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 2
- (2016) Naoki Tsuno et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Modulation of TRPV4 by diverse mechanisms
- (2016) W.G. Darby et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch
- (2016) Yong Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TRPV4: Molecular Conductor of a Diverse Orchestra
- (2016) John P. M. White et al. PHYSIOLOGICAL REVIEWS
- A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis
- (2016) Suowen Xu et al. Oncotarget
- TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation
- (2015) Roslin J. Thoppil et al. Scientific Reports
- TRPV4: physiological role and therapeutic potential in respiratory diseases
- (2014) Neil M. Goldenberg et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The puzzle of TRPV4 channelopathies
- (2013) Bernd Nilius et al. EMBO REPORTS
- Determining target engagement in living systems
- (2013) Gabriel M Simon et al. Nature Chemical Biology
- UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling
- (2013) Carlene Moore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure
- (2012) Kevin S. Thorneloe et al. Science Translational Medicine
- Identification of false positives in “HTS hits to lead”: The application of Bayesian models in HTS triage to rapidly deliver a series of selective TRPV4 antagonists
- (2012) Sarah E. Skerratt et al. MedChemComm
- Heteromeric TRPV4-C1 channels contribute to store-operated Ca2+ entry in vascular endothelial cells
- (2011) Xin Ma et al. CELL CALCIUM
- TRPV4 Agonists and Antagonists
- (2011) Fabien Vincent et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Atomic Force Microscopy Reveals the Alternating Subunit Arrangement of the TRPP2-TRPV4 Heterotetramer
- (2010) Andrew P. Stewart et al. BIOPHYSICAL JOURNAL
- Activation of Trpv4 Reduces the Hyperproliferative Phenotype of Cystic Cholangiocytes From an Animal Model of ARPKD
- (2010) Sergio A. Gradilone et al. GASTROENTEROLOGY
- Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis
- (2010) W. Everaerts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a Protein Kinase C-dependent phosphorylation site involved in sensitization of TRPV4 channel
- (2009) Hongquan Peng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of the TRPV4 Ion Channel Is Enhanced by Phosphorylation
- (2009) Hueng-Chuen Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started